Exact Mass: 532.1836
Exact Mass Matches: 532.1836
Found 500 metabolites which its exact mass value is equals to given mass value 532.1836
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Flavonol 3-O-D-xylosylglycoside
Sesaminol glucoside
Sesaminol glucoside is found in cereals and cereal products. Sesaminol glucoside is a constituent of sesame seed. Constituent of sesame seed. Sesaminol glucoside is found in cereals and cereal products.
Ponatinib
Ponatinib is a Bcr-Abl tyrosine kinase inhibitor that is especially effective against the T315I mutation for the treatment of chronic myeloid leukemia. FDA approved on December 14, 2012 (DB08901). L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163790 - Flt-3-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
3-[3-[4-[5-(2-Carboxyethyl)-2-hydroxyphenyl]-1,4-bis(carboxymethylamino)butyl]-4-hydroxyphenyl]propanoic acid
Plevitrexed
Isoscutellarein 4-methyl ether 8-(6-n-butylglucuronide)
2-O-(2-Methylbutyryl)orientin
Luteolin 7-[6-(2-methylbutyryl)glucoside]
4-Hydroxyrottlerin
5,7-Dihydroxy-6-C-methylflavone 7-xylosyl- (1->3) -xyloside
4-[(beta-D-glucopyranosyl)oxy]-2-(hydroxymethyl)-3-(3-methylbut-2-en-1-yl)phenyl beta-D-glucopyranoside|clemomandshuricoside C
5,4-dihydroxy-3-methoxyflavone-7-O-6-n-butyryl-beta-D-glucopyranoside|luteolin-3-O-methyl-7-O-(6-butyryl-beta-glucopyranoside)
6-gamma,gamma-dimethylallylquercetin 7-O-beta-D-glucoside
5-methoxy-6-methyl-7-[O-beta-D-glucopyranoside]- 8-aldehydo-3-(3,4-methylenedioxybenzyl)chroman-4-one|ophiopogoside B
(2E)-22-demethyl-2,3-didehydro-3-deoxy-maytansinol|(3E,5E,7R,84S,12E)-14-chloro-10t,11c-epoxy-84-hydroxy-15,7r-dimethoxy-3,9c,11t-trimethyl-(84rH,86cH)-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5,12-triene-82,14-dione|Normaysin|Normaysin (6)|normaysine
1alpha-acetoxy-6beta,9beta-difuroyloxy-2alpha,4beta-dihydroxy-dihydro-beta-agarofuran
3,3-dioxo-6,11,6,11-tetrahydro-5H,5H-[2,2]bi[indolizino[8,7-b]indolylidene]-5,5-dicarboxylic acid|Trichotomin|Trichotomine
7,8-dihydroxy-5-methoxycoumarin-7-beta-sophoroside
1-[6-[(3-acetyl-2,4,6-trihydroxy-5-methylphenyl)methyl]-5,7-dihydroxy-2,2-dimethylchromen-8-yl]-3-(4-hydroxyphenyl)prop-2-en-1-one
benzyl-7-O-(5-O-trans-cinnamoyl-beta-D-apiosyl)-(1->3)-beta-D-glucopyranoside
6-C-beta-D-glucopyranosyl-8-C-alpha-L-arabinosylapigenin|schaftside
6-C-alpha-L-arabinosyl-8-C-beta-D-glucopyranosylapigenin
3-[gamma-hydroxymethyl-(z)-gamma-methylallyl]-2,4,2,4-tetrahydroxychalcone 11-O-ferulate|gemichalcone C
1-O-(E)-feruloyl-(beta-<1->2>-glucuronosyl)-beta-glucose|1-O-(E)-feruloyl-[beta-(1->2)-glucuronosyl]-beta-glucose
His Val Tyr Asp
Asn Asp Glu Arg
Asp His Phe Asp
5,7-Dihydroxy-6-C-methylflavone 7-xylosyl-(1->3)-xyloside
1-O-Deacetyl-2α-hydroxykhayanolide E
Ala Glu Gln Trp
Ala Glu Trp Gln
Ala Gln Glu Trp
Ala Gln Trp Glu
Ala Trp Glu Gln
Ala Trp Gln Glu
Cys Phe Thr Tyr
Cys Phe Tyr Thr
Cys His His His
Cys Pro Gln Trp
Cys Pro Trp Gln
Cys Gln Pro Trp
Cys Gln Trp Pro
Cys Thr Phe Tyr
Cys Thr Tyr Phe
Cys Trp Pro Gln
Cys Trp Gln Pro
Cys Tyr Phe Thr
Cys Tyr Thr Phe
Asp Asp Phe His
Asp Asp His Phe
Asp Asp Gln Arg
Asp Asp Arg Gln
Asp Glu Asn Arg
Asp Glu Arg Asn
Asp Phe Asp His
Asp Phe His Asp
Asp His Asp Phe
Asp His Met Met
Asp His Val Tyr
Asp His Tyr Val
Asp Met His Met
Asp Met Met His
Asp Asn Glu Arg
Asp Asn Arg Glu
Asp Asn Val Trp
Asp Asn Trp Val
Asp Gln Asp Arg
Asp Gln Arg Asp
Asp Arg Asp Gln
Asp Arg Glu Asn
Asp Arg Asn Glu
Asp Arg Gln Asp
Asp Val His Tyr
Asp Val Asn Trp
Asp Val Trp Asn
Asp Val Tyr His
Asp Trp Asn Val
Asp Trp Val Asn
Asp Tyr His Val
Asp Tyr Val His
Glu Ala Gln Trp
Glu Ala Trp Gln
Glu Asp Asn Arg
Glu Asp Arg Asn
Glu Glu Gln Gln
Glu Phe His Thr
Glu Phe Thr His
Glu His Phe Thr
Glu His Thr Phe
Glu Asn Asp Arg
Glu Asn Arg Asp
Glu Gln Ala Trp
Glu Gln Glu Gln
Glu Gln Gln Glu
Glu Gln Trp Ala
Glu Arg Asp Asn
Glu Arg Asn Asp
Glu Thr Phe His
Glu Thr His Phe
Glu Trp Ala Gln
Glu Trp Gln Ala
Phe Cys Thr Tyr
Phe Cys Tyr Thr
Phe Asp Asp His
Phe Asp His Asp
Phe Glu His Thr
Phe Glu Thr His
Phe His Asp Asp
Phe His Glu Thr
Phe His Thr Glu
Phe Thr Cys Tyr
Phe Thr Glu His
Phe Thr His Glu
Phe Thr Tyr Cys
Phe Tyr Cys Thr
Phe Tyr Thr Cys
Gly Met Tyr Tyr
Gly Tyr Met Tyr
Gly Tyr Tyr Met
His Cys His His
His Asp Asp Phe
His Asp Phe Asp
His Asp Met Met
His Asp Val Tyr
His Asp Tyr Val
His Glu Phe Thr
His Glu Thr Phe
His Phe Asp Asp
His Phe Glu Thr
His Phe Thr Glu
His His Cys His
His His His Cys
His Met Asp Met
His Met Met Asp
His Thr Glu Phe
His Thr Phe Glu
His Val Asp Tyr
His Tyr Asp Val
His Tyr Val Asp
Met Asp His Met
Met Asp Met His
Met Gly Tyr Tyr
Met His Asp Met
Met His Met Asp
Met Met Asp His
Met Met His Asp
Met Tyr Gly Tyr
Met Tyr Tyr Gly
Asn Asp Arg Glu
Asn Asp Val Trp
Asn Asp Trp Val
Asn Glu Asp Arg
Asn Glu Arg Asp
Asn Arg Asp Glu
Asn Arg Glu Asp
Asn Val Asp Trp
Asn Val Trp Asp
Asn Trp Asp Val
Asn Trp Val Asp
Pro Cys Gln Trp
Pro Cys Trp Gln
Pro Gln Cys Trp
Pro Gln Trp Cys
Pro Trp Cys Gln
Pro Trp Gln Cys
Gln Ala Glu Trp
Gln Ala Trp Glu
Gln Cys Pro Trp
Gln Cys Trp Pro
Gln Asp Asp Arg
Gln Asp Arg Asp
Gln Glu Ala Trp
Gln Glu Glu Gln
Gln Glu Gln Glu
Gln Glu Trp Ala
Gln Pro Cys Trp
Gln Pro Trp Cys
Gln Gln Glu Glu
Gln Arg Asp Asp
Gln Trp Ala Glu
Gln Trp Cys Pro
Gln Trp Glu Ala
Gln Trp Pro Cys
Arg Asp Asp Gln
Arg Asp Glu Asn
Arg Asp Asn Glu
Arg Asp Gln Asp
Arg Glu Asp Asn
Arg Glu Asn Asp
Arg Asn Asp Glu
Arg Asn Glu Asp
Arg Gln Asp Asp
Ser Thr Tyr Tyr
Ser Tyr Thr Tyr
Ser Tyr Tyr Thr
Thr Cys Phe Tyr
Thr Cys Tyr Phe
Thr Glu Phe His
Thr Glu His Phe
Thr Phe Cys Tyr
Thr Phe Glu His
Thr Phe His Glu
Thr Phe Tyr Cys
Thr His Glu Phe
Thr His Phe Glu
Thr Ser Tyr Tyr
Thr Tyr Cys Phe
Thr Tyr Phe Cys
Thr Tyr Ser Tyr
Thr Tyr Tyr Ser
Val Asp His Tyr
Val Asp Asn Trp
Val Asp Trp Asn
Val Asp Tyr His
Val His Asp Tyr
Val His Tyr Asp
Val Asn Asp Trp
Val Asn Trp Asp
Val Trp Asp Asn
Val Trp Asn Asp
Val Tyr Asp His
Val Tyr His Asp
Trp Ala Glu Gln
Trp Ala Gln Glu
Trp Cys Pro Gln
Trp Cys Gln Pro
Trp Asp Asn Val
Trp Asp Val Asn
Trp Glu Ala Gln
Trp Glu Gln Ala
Trp Asn Asp Val
Trp Asn Val Asp
Trp Pro Cys Gln
Trp Pro Gln Cys
Trp Gln Ala Glu
Trp Gln Cys Pro
Trp Gln Glu Ala
Trp Gln Pro Cys
Trp Val Asp Asn
Trp Val Asn Asp
Tyr Cys Phe Thr
Tyr Cys Thr Phe
Tyr Asp His Val
Tyr Asp Val His
Tyr Phe Cys Thr
Tyr Phe Thr Cys
Tyr Gly Met Tyr
Tyr Gly Tyr Met
Tyr His Asp Val
Tyr His Val Asp
Tyr Met Gly Tyr
Tyr Met Tyr Gly
Tyr Ser Thr Tyr
Tyr Ser Tyr Thr
Tyr Thr Cys Phe
Tyr Thr Phe Cys
Tyr Thr Ser Tyr
Tyr Thr Tyr Ser
Tyr Val Asp His
Tyr Val His Asp
Tyr Tyr Gly Met
Tyr Tyr Met Gly
Tyr Tyr Ser Thr
Tyr Tyr Thr Ser
Sesaminol glucoside
Plevitrexed
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C272 - Antimetabolite C471 - Enzyme Inhibitor > C2021 - Thymidylate Synthase Inhibitor D000970 - Antineoplastic Agents
n6-(6-aminohexyl)adenosine 2,5-diphosphate lithium salt
BENZOIC ACID, 4-[4-[(3R)-3-[[[2-OXO-2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO]ETHYL]AMINO]CARBONYL]-1-PYRROLIDINYL]-1-PIPERIDINYL]-, METHYL ESTER
Oprozomib
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor C471 - Enzyme Inhibitor
Bis(tert-butoxy)bis(1-methoxy-2-methyl-2-propoxy)hafnium(IV)
4,6-bis(3-(2-ethylhexyl)thien-2-yl)thieno[3,4-c][1,2,5]thiadiazole
Onvansertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C177899 - PLK1 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Regrelor
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent > C190801 - P2Y12 Inhibitor D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists
Benzamide, 4-methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1,2,4-triazolo(4,3-a)pyridin-3-yl)ethynyl)-
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Pirbenicillin sodium
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
N2,N7-Bis(2,5-dimethylphenyl)-9H-fluorene-2,7-disulfonamide
Ponatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EA - Bcr-abl tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163790 - Flt-3-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164037 - PDGFR-targeting Agent C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163999 - cKIT-targeting Agent C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159198 - c-KIT Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159438 - RET Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C155700 - BCR-ABL Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
longipedumin A
A lignan isolated from the roots and stems of Kadsura longipedunculata and has been shown to exhibit inhibitory activity against HIV-1 protease.
(2R,3R)-5,5,6,6,8,8-hexahydroxy-2,2,3-trimethyl-2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione
2-(4-Acetoxy-3-ethoxy-benzylidene)-7-methyl-3-oxo-5-styryl-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl ester
flavonol 3-O-D-xylosyl-D-galactoside
A glycosyloxyflavone that consists of flavonol attached to a D-xylosyl-D-galactosyl residue at position 3 via a glycosidic linkage.
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3S,6aS,8R,10aS)-1-(3,5-dichlorobenzoyl)-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2S,3R)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
2-[(3R,6aR,8R,10aR)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(1S)-N-(4-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
N-[[(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-4-fluoro-N-methylbenzenesulfonamide
3-chloro-N-[(2R)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
3-chloro-N-[(2S)-1-hydroxypropan-2-yl]-N-[(2R,3S)-3-methoxy-2-methyl-4-[methyl-(4-methylphenyl)sulfonylamino]butyl]benzenesulfonamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(4-methylphenyl)sulfonyl-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(1,3-benzodioxol-5-ylmethyl)acetamide
2-[(3R,6aR,8S,10aR)-1-[(3,5-dichlorophenyl)-oxomethyl]-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-1-(3,4-dihydro-1H-isoquinolin-2-yl)ethanone
(1R)-N-(2-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
(1R)-N-(4-fluorophenyl)-1-[(2-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-7-methoxy-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]carboxamide
flavonol 3-O-D-xylosyl-D-glucoside
A glycosyloxyflavone that consists of flavonol attached to a D-xylosyl-D-glucosyl residue at position 3 via a glycosidic linkage.
6-[4-[6-Carboxy-5-(2,6-dihydroxyphenyl)-3-methylcyclohex-3-en-1-yl]-3-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
3,4,5-Trihydroxy-6-[[4-hydroxy-7-methoxy-2,2-dimethyl-6-(3-phenylpropanoyl)-3,4-dihydrochromen-5-yl]oxy]oxane-2-carboxylic acid
8-[1-(2,4-dihydroxyphenyl)-2-hydroxy-3-(3-hydroxyphenyl)propyl]-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol
sesaminol 2-O-beta-D-glucoside
A beta-D-glucoside that is sesaminol in which the hydroxy group at position 5 is substituted by a beta-D-glucopyranoside group. A metabolite found in sesame seeds.
chaetochromin C
A biaryl that is 2,2,3,3-tetrahydro-4H,4H-9,9-bibenzo[g]chromene-4,4-dione substituted by hydroxy groups at positions 5, 5, 6, 6, 8 and 8 and methyl groups at positions 2, 2 and 3 (the 2R,3R stereoisomer). It has been isolated from Chaetomium gracile.
cercosporin(2-)
A phenolate anion resulting from the deprotonation of the two hydroxy groups at position 5 and 12 of cercosporin. Major microspecies at pH 7.3.
IPN60090
IPN-60090 is an orally active and highly selective inhibitor of glutaminase 1?(GLS1; IC50=31 nM), with no activity observed against GLS-2. IPN-60090 exhibits excellent physicochemical and pharmacokinetic properties in vivo. IPN-60090 can be used for solid tumors research, such as lung and ovarian cancers[1][2].